Home › Funds › PFM Health Sciences, LP › JAZZ
PFM Health Sciences, LP position in JAZZ
JAZZ PHARMACEUTICALS PLC SHS USD · Health Care
PFM Health Sciences, LP reported holding 160,768 shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) in its Q2 2026 13F filing — a position valued at US$38.7M, representing 3.39% of its reported portfolio and ranking #4 among its reported holdings. PFM Health Sciences, LP has disclosed JAZZ holdings in 4 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's JAZZ position evolved
PFM Health Sciences, LP first disclosed a stake in JAZZ in Q4 2024 at 17,597 shares (US$2.2M). The position peaked in Q2 2026 at 160,768 shares, worth US$38.7M. Across 4 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 160,768 shares valued at US$38.7M — a reduction of -17,376 shares quarter over quarter.. Notable position changes include a 253% increase in Q1 2026 (shares rose 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 17.60K | $2.17M | New |
| Q4 2025 | 50.51K | $8.59M | New |
| Q1 2026 | 178.14K | $33.68M | Add |
| Q2 2026 | 160.77K | $38.74M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JAZZ and 13F data
JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD) is a Health Care company. 44 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$394.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), GMT CAPITAL CORP (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JAZZ
- FULLER & THALER ASSET MANAGEMENT, INC. 1.64M sh · $394.84M · Q2 2026
- MILLENNIUM MANAGEMENT LLC 763.88K sh · $184.07M · Q2 2026
- GMT CAPITAL CORP 453.50K sh · $109.28M · Q2 2026
- Boston Trust Walden Corp 443.12K sh · $106.78M · Q2 2026
- SYSTEMATIC FINANCIAL MANAGEMENT LP 378.71K sh · $91.26M · Q2 2026
- Sofinnova Investments, Inc. 365.34K sh · $88.04M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held JAZZ?
PFM Health Sciences, LP has disclosed JAZZ holdings in 4 of the last 7 reported quarters, going back to Q4 2024.
What is PFM Health Sciences, LP's current position in JAZZ?
As of Q2 2026, PFM Health Sciences, LP holds 160.77K shares of JAZZ (JAZZ PHARMACEUTICALS PLC SHS USD), valued at $38.74M, representing 3.39% of its reported portfolio and ranking #4.
Has PFM Health Sciences, LP been buying or selling JAZZ?
In the latest 13F filing (Q2 2026), PFM Health Sciences, LP reduced its position in JAZZ. The position peaked in Q2 2026 at 160.77K shares.
Which other funds hold JAZZ?
Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, GMT CAPITAL CORP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.